2017 News Releases

Date Title   10/31/17 Lombard Medical Reports First Half and Third Quarter 2017 Financial Results OXFORDSHIRE, U.K.--(BUSINESS WIRE)--Oct. 31, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms (AAA), today reported unaudited year-to-date financial results for the first nine months ended September 30, 2017. 2017 Operational Highlights Appointment of Kurt Lemvigh as CEO, April 2017 Appointment of Richard Peace as ...  10/30/17 Lombard Medical Announces Shares to Trade on OTCQX OXFORDSHIRE, U.K.--(BUSINESS WIRE)--Oct. 30, 2017-- Lombard Medical, Inc. (Nasdaq: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms (AAA), today announced that it has notified Nasdaq of its intention to voluntarily delist the Company’s shares from the Nasdaq Capital Market (“Nasdaq”) and transfer its listing to the OTCQX. Lombard anticipates that its common shares will trade under its existing ...  09/26/17 Lombard Medical's New Delivery System for Aorfix(TM) Endovascular Aortic Aneurysm Repair System Launched in Japan OXFORDSHIRE, England--(BUSINESS WIRE)--Sep. 26, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular abdominal aortic aneurysm (AAA) endovascular repair products, today announced the full commercial launch in Japan of its new low-profile IntelliFlex™ LP delivery system for the Aorfix™ AAA system. The new delivery system, used to deliver Lombard’s Aorfix AAA stent graph, is exclusively marketed...  09/20/17 Lombard Medical Appoints Jonathan Hornsby as Vice President, Sales & Marketing Veteran European Sales Manager of Endovascular Aneurysm Repair Market with Extensive Clinical and UK Experience OXFORDSHIRE, England--(BUSINESS WIRE)--Sep. 20, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced the appointment of Jonathan Hornsby as Vice President, Sales & Marketing, effective immediately. Jonathan Hornsby brings over ...  09/13/17 Lombard Medical Announces Completion of Restructuring and Implementation of Strategic Plan to Achieve Profitability OXFORDSHIRE, England--(BUSINESS WIRE)--Sep. 13, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced completion of a restructuring following the implementation of its new strategy to focus sales efforts in the UK, Japan and China, and reduce operating and manufacturing costs in order to achieve cash flow breakeven in the near term. The restructu...  05/15/17 Lombard Medical Announces First Patient Enrolled and Treated in the ALTITUDE Registry for the Altura® Stent Graft System OXFORDSHIRE, U.K.--(BUSINESS WIRE)--May 15, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that it has enrolled and treated the first patient in its global registry to evaluate its Altura® Endograft System. The ALTITUDE registry (ALTura Impact on the Treatment of Abdominal Aortic Aneurysms Using a Novel D-stent EVAR Design) is being conduc...  05/04/17 Lombard Medical's Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium OXFORDSHIRE, U.K.--(BUSINESS WIRE)--May 4, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that its portfolio of endovascular stent graft systems, Altura® and Aorfix™, were featured in scientific presentations at the 39th annual Charing Cross International Symposium in London on April 25 - 26. Altura Presentations Altura clinical da...  04/20/17 Lombard Medical Appoints New CEO OXFORDSHIRE, England--(BUSINESS WIRE)--Apr. 20, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Kurt Lemvigh has been appointed as its new Chief Executive Officer, effective immediately. Lemvigh is a veteran medical device executive with over 30 years of experience creating profitable growth. He currently resides in the U.K. and has he...  04/18/17 Lombard Medical Reports 2016 Fourth Quarter, Full Year Financial Results OXFORDSHIRE, U.K.--(BUSINESS WIRE)--Apr. 18, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms, today reported financial results for the fourth quarter and year ended December 31, 2016. Recent Operational Highlights The signing of a strategic partnership with MicroPort Scientific Corporation (HK: 0853), a leading global manufacture...  04/18/17 Lombard Medical’s CEO Steps Down OXFORDSHIRE, England--(BUSINESS WIRE)--Apr. 18, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Simon Hubbert has stepped down from his position as CEO on April 18 after serving in the role for more than six years. A search is underway for a successor and an announcement is expected in due course. Hubbert joined Lombard during 2010 and...  04/03/17 Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements Operational Foundation Established for Improved Gross Margins and Access to the Fast-Growing China Endovascular Market OXFORDSHIRE, U.K. & SHANGHAI--(BUSINESS WIRE)--Apr. 3, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer and marketer of a diversified portfolio of medical devices, today announced th...  02/07/17 Lombard Medical Announces Successful Completion of First 15 Cases in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent Graft OXFORDSHIRE, England--(BUSINESS WIRE)--Feb. 7, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that physicians in Japan have successfully treated the first 15 patients using its innovative new IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent Graft since launch on February 1, 2017. Aorfix with IntelliF...  01/05/17 Lombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft Exclusive Japanese Partner Medico’s Hirata Anticipates Market Share Gain Following Launch in Early 2017 OXFORDSHIRE, England--(BUSINESS WIRE)--Jan. 5, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced approval from the Japanese Ministry of Health, Labour and Welfare for its IntelliFlex™ Low Profile (LP) Delivery System for t...